HEALTH-RELATED QUALITY OF LIFE FOR DISEASE-MODIFYING THERAPIES AMONG PATIENTS WITH SPINAL MUSCULAR ATROPHY IN TAIWAN

被引：0
|
作者：
Chiang, W. [1 ]
Hsieh, H. M. [1 ]
Jong, Y. J. [2 ]
机构：
[1] Kaohsiung Med Univ, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCR48
引用
收藏
页码：S304 / S305
页数：2
相关论文
共 50 条
  • [1] Health-related quality of life of children with spinal muscular atrophy in Sweden: A prospective cohort study in the era of disease-modifying therapy
    Landfeldt, Erik
    Udo, Camilla
    Lovgren, Malin
    Sejersen, Thomas
    Kreicbergs, Ulrika
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2023, 46 : 67 - 73
  • [2] Mortality in Spinal Muscular Atrophy in the era of disease-modifying therapies
    Finnegan, R.
    Rohwer, A.
    Scoto, M.
    Main, M.
    Baranello, G.
    Manzur, A.
    Muntoni, F.
    Munot, P.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [3] Molecular Pathophysiology and Disease-Modifying Therapies for Spinal and Bulbar Muscular Atrophy
    Katsuno, Masahisa
    Banno, Haruhiko
    Suzuki, Keisuke
    Adachi, Hiroaki
    Tanaka, Fumiaki
    Sobue, Gen
    ARCHIVES OF NEUROLOGY, 2012, 69 (04) : 436 - 440
  • [4] COST-EFFECTIVENESS OF UNIVERSAL NEWBORN SCREENING FOR SPINAL MUSCULAR ATROPHY WITH DISEASE-MODIFYING THERAPIES IN TAIWAN
    Chiang, W.
    Hsieh, H. M.
    Jong, Y. J.
    VALUE IN HEALTH, 2024, 27 (06) : S76 - S76
  • [5] Mortality of symptomatic children with spinal muscular atrophy in the era of disease-modifying therapies
    Finnegan, R.
    Rohwer, A. M.
    Scoto, M.
    Main, M.
    Baranello, G.
    Manzur, A.
    Muntoni, F.
    Munot, P.
    NEUROMUSCULAR DISORDERS, 2025, 49
  • [6] Health-related quality of life in Thai children with spinal muscular atrophy
    Aksaralikitsunti, Manassanan
    Sanmaneechai, Oranee
    PEDIATRICS AND NEONATOLOGY, 2022, 63 (03): : 291 - 297
  • [7] Health-Related Quality of Life in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs
    Peter Joseph Jongen
    CNS Drugs, 2017, 31 : 585 - 602
  • [8] Health-Related Quality of Life in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs
    Jongen, Peter Joseph
    CNS DRUGS, 2017, 31 (07) : 585 - 602
  • [9] Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies An Italian Nationwide Survey
    Coratti, Giorgia
    Ricci, Martina
    Capasso, Anna
    D'amico, Adele
    Sansone, Valeria
    Bruno, Claudio
    Messina, Sonia
    Ricci, Federica
    Mongini, Tiziana
    Coccia, Michela
    Siciliano, Gabriele
    Pegoraro, Elena
    Turri, Mara
    Filosto, Massimiliano
    Comi, Giacomo
    Masson, Riccardo
    Maggi, Lorenzo
    Bruno, Irene
    D'Angelo, Maria Grazia
    Trabacca, Antonio
    Vacchiano, Veria
    Donati, Maria
    Simone, Isabella
    Ruggiero, Lucia
    Varone, Antonio
    Verriello, Lorenzo
    Berardinelli, Angela
    Agosto, Caterina
    Pini, Antonella
    Maioli, Maria Antonietta
    Passamano, Luigia
    Brighina, Filippo
    Carboni, Nicola
    Garibaldi, Matteo
    Zuccarino, Riccardo
    Gagliardi, Delio
    Siliquini, Sabrina
    Previtali, Stefano
    Taruscio, Domenica
    Boccia, Stefania
    Pera, Maria Carmela
    Pane, Marika
    Mercuri, Eugenio
    NEUROLOGY, 2023, 100 (11) : 522 - 528
  • [10] Respiratory morbidity in patients with spinal muscular atrophy-a changing world in the light of disease-modifying therapies
    Lagae, Leen
    Proesmans, Marijke
    Van den Hauwe, Marleen
    Vermeulen, Francois
    De Waele, Liesbeth
    Boon, Mieke
    FRONTIERS IN PEDIATRICS, 2024, 12
12345